Abstract
This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body's immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options.
| Original language | English |
|---|---|
| Number of pages | 1 |
| Journal | Journal of experimental & clinical cancer research : CR |
| Volume | 37 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Oct 30 2018 |
Fingerprint
Keywords
- Anti-tumor immune response
- CTLA-4
- Immune checkpoints
- Immunotherapy
- PD-1
- PD-L1
ASJC Scopus subject areas
- Oncology
- Cancer Research
Cite this
Nobel committee honors tumor immunologists. / Rotte, Anand; D'Orazi, Gabriella; Bhandaru, Madhuri.
In: Journal of experimental & clinical cancer research : CR, Vol. 37, No. 1, 30.10.2018.Research output: Contribution to journal › Editorial
}
TY - JOUR
T1 - Nobel committee honors tumor immunologists
AU - Rotte, Anand
AU - D'Orazi, Gabriella
AU - Bhandaru, Madhuri
PY - 2018/10/30
Y1 - 2018/10/30
N2 - This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body's immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options.
AB - This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body's immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options.
KW - Anti-tumor immune response
KW - CTLA-4
KW - Immune checkpoints
KW - Immunotherapy
KW - PD-1
KW - PD-L1
UR - http://www.scopus.com/inward/record.url?scp=85055627847&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055627847&partnerID=8YFLogxK
U2 - 10.1186/s13046-018-0937-6
DO - 10.1186/s13046-018-0937-6
M3 - Editorial
VL - 37
JO - Journal of Experimental and Clinical Cancer Research
JF - Journal of Experimental and Clinical Cancer Research
SN - 0392-9078
IS - 1
ER -